Sickle cell patients share delight over approval of new treatment
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also ...
hospitalnews1d
A pathway to independence for patients with rare disease
Learn about dermatomyositis and the remarkable journey of Audrey Gouskos. Discover how St. Michael's Hospital has provided lifesaving support for her rare disease.
Zacks.com on MSN1d
Sanofi Misses on Q4 Earnings & Sales, Expects Higher Profits in 2025
Sanofi SNY reported fourth-quarter 2024 adjusted earnings of 70 cents per American depositary share, which missed the Zacks Consensus Estimate of 71 cents per share. Earnings of €1.31 per share ...
The Financial Express1d
Rare disease patients urge PM Modi to address delay in Rs 974 crore national programme roll-out
According to the open letter, the delay in rolling out the proposed ₹ 974 crore national programme on rare diseases has exacerbated these challenges, leaving patients, most of whom are children, in ...
India Today1d
Rare disease patients in crisis as delays stall national policy implementation
Patient advocacy groups warned that delays in implementing India's rare disease policy have left many, including children, in ...
Next-generation tau radiotracers outperform FDA-approved imaging agents in detecting Alzheimer's disease
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...